BVI to launch new SERENITY and SERENITY Toric monofocal IOLs

News
Article

The new, non-diffractive IOLs are the second generation of BVI’s ISOPURE premium monofocal IOL that was launched in 2019.

Doctor performing cataract surgery Image credit: AdobeStock/Kate

Image credit: AdobeStock/Kate

Ophthalmic device company BVI has announced that its new SERENITY and SERENITY Toric premium monofocal IOLs will be fully commercial available in CE-accepting markets in 2025.1 The new, non-diffractive IOLs are the second generation of BVI’s ISOPURE premium monofocal IOL that was launched in 2019, according to a news release.

“As we launch the second-generation SERENITY and SERENITY Toric IOLs, BVI views this IOL as potentially a game-changer when it comes to standard of care for monofocal procedures,” said Shervin Korangy, president and CEO of BVI, in the release. “Our portfolio includes a wide range of IOLs, meticulously designed from material to haptics to optics to provide the optimal outcome without the burden of retro-fitting legacy predicate devices.”

The IOL also features ISOFOCAL optic technology to aid in clear distance vision and intermediate vision by balancing depth of focus and image quality. This allows the lens to provide far vision equal to a monofocal but with adequate intermediate vision up to 66 cm. Additionally, the lens’ double c-loop POD platform is specifically designed to deliver precise astigmatism correction and stable IOL positioning, according to the release. Those with astigmatism benefit with stability in the capsular bag, which results in outcomes accurately predicted by BVI’s toric calculator.1

The SERENITY series’ ISOFOCAL technology also works in favor of stability by delivering spherical aberration correction across the entire optic diameter and customizable levels of spherical aberration per dioptric power, the release said.

Sheraz Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth, of Centre For Sight, UK, was 1 of the first surgeons to implant SERENITY. “It is wonderful to see this increased range of focus lens on the same platform as the Finevision with 4 C loop haptics,” he said in the release. “I look forward to the Toric version as well which I know will be very stable with no rotation.”

BVI plans to launch the new IOL during the 2024 European Society of Cataract and Refractive Surgeons meeting in Fira de Barcelona, Spain from September 6-10.

Reference:
  1. BVI to launch new SERENITY and SERENITY toric premium monofocal IOLs. News release. BVI. September 3, 2024. Accessed September 4, 2024. https://www.bvimedical.com/us/bvi-to-launch-new-serenity-and-serenity-toric-premium-monofocal-iols/

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
© 2025 MJH Life Sciences

All rights reserved.